semaglutide우선순위 낮음근거 검토기타
LITERATURE DETAIL · PMID 42622752
Oral semaglutide vs DPP-4 inhibitors in reducing risk of cognitive impairment in elderly patients with HFpEF and obesity.
Oral semaglutide vs DPP-4 inhibitors in reducing risk of cognitive impairment in elderly patients with HFpEF and obesity.
- 저자
- Giuseppe Armentaro, Cristiana Vitale, Velia Cassano, Marilisa Panza, Ilaria Gareri, Maria Mirabelli
- 저널
- Internal and emergency medicine
- 공개일
- 2026 Aug 20
- 연구 유형
- 기타
- DOI
- 10.1007/s11739-026-04499-4
문헌 요약
Heart failure with preserved ejection fraction (HFpEF), obesity, type 2 diabetes mellitus are common in elderly patients and are associated with an increased risk of cognitive impairment (CoI). In these patients, the protective metabolic and vascular effects of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are well established. The aim of this stu…
PV 검토 포인트
누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.